Figure INF-3:  HIV prevalence among injecting drug users – studies with national and sub-national coverage – Part (iii) All injecting drug users by gender, age, years of injecting and primary drug (where data available), 2000 to 2004

Notes:

Gender:

Countries with data available for the gender: Austria, Belgium, Bulgaria, Czech Republic, Germany, Estonia, Spain, Finland, France, Greece, Hungary, Italy, Lithuania, Luxembourg, Latvia, Malta, The Netherlands, Poland, Slovenia, Slovakia and United Kingdom.

Number of samples: 539 (275 males; 264 females)

Total sample size: 485195

407554 (males); 77641 (females).

Age:

Countries with data available for age: Austria, Belgium, Bulgaria, Czech Republic, Estonia, Spain, Finland, France, Greece, Hungary, Lithuania, Luxembourg, Latvia, Malta, Poland, Portugal, Slovenia, Slovakia, Turkey, United Kingdom.

Number of samples: 425 (155, <25); (137, 25-34); (133, >34).

Total sample size: 141009

27159 (<25); 56235 (25-34); 57615 (>34)

Years of injection:

Countries with data available for years of injection: Austria, Belgium, Spain, France, Greece, Lithuania, Latvia, Poland, Portugal, Slovenia, Turkey, United Kingdom.

Number of samples: 135 (65, <2 years); (70, >2 years)

Total sample size: 22529

2701 (<2 years); 19558 (>2 years)

Primary drug:

Countries with data available for primary drug: Austria, Belgium, Bulgaria, Czech Republic, Germany, Spain, France, Greece, Latvia, Lithuania, Malta, Poland, Portugal, Slovenia, Slovakia, Turkey.

Number of samples: 143 (78 opiates; 65 non-opiates)

Total sample size: 66870

522 (non-opiates); 66348 (opiates)

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

National Focal Points.